A double-blind, placebo-controlled trial with 95 participants found that daily consumption of fresh coconut water for eight weeks led to an 88% improvement in gut inflammation symptoms among those with mild to moderate ulcerative colitis, according to researchers. The study reported a 53% clinical remission rate in the coconut water group compared to 28% in the placebo group, with significantly lower markers of gut inflammation, the report stated. The trial was conducted by a team of researchers and the results were documented in a clinical study, according to a report on NaturalNews.com [1]. The findings indicate that a simple dietary…
Newswire
Prevalence and Link to Fatigue Approximately 40% to 75% of the teen and adult population in the United States is…
Constipation Affects Up to 20% of U.S. Adults Chronic constipation affects an estimated 20% of the general adult population in…
The article describes a resurgence of interest in Ayurveda, a 5,000-year-old Indian medical system, as a natural and preventative approach…
Oil Trader Nets Estimated $125 Million on Suspiciously Timed Bet Ahead of U.S.-Iran Deal Report Nearly 10,000 crude oil short…
Key Takeaways A Raleigh woman shot her ex-boyfriend in self-defense after he vandalized her car and fired shots at her…
Features
The Latest
The U.S. and Israel launched a massive, coordinated military strike against Iran, dubbed Operation Epic Fury, on February 28. The operation…
The United States was behind a strike on an Iranian school that killed 168 children and staff members. The February…
President Trump announced he would halt all trade with Spain after Madrid denied U.S. forces access to Spanish military bases…
A 46-year-old woman, Stannita Wilson, has been charged with second-degree burglary after a Des Moines homeowner shot her during a…
CIA arming Kurdish forces to spark uprising against Iran, raising fears of wider conflict The Central Intelligence Agency (CIA)…
As you age, maintaining strength becomes about far more than just fitness. Starting as early as our 40s, we begin…